Cordyceps And VO2 Max: The Study Record
The whole human record for Cordyceps and peak oxygen uptake comes down to a handful of small trials, and they disagree with each other. A 2025 systematic review found 14 randomised controlled trials of fungal supplementation in athletes published between 2004 and 2024, with 528 participants in total, and could pool only eight of them. For peak oxygen uptake specifically, the pooled estimate rests on two or three studies.
That is a thin evidence base to hang a category on. It is worth reading carefully anyway, because the individual trials are more interesting than the summary, and because the disagreements between them are where the useful information is.
What the Cordyceps VO2 max studies measured, and in whom
The review is by Shu and colleagues in Frontiers in Nutrition, 2025, registered on PROSPERO, and it tabulates each included trial. The Cordyceps arm of it looks like this.
| Trial | Material | Participants | Dose | Duration | Oxygen-uptake result |
|---|---|---|---|---|---|
| Parcell, 2004 | C. sinensis | 22 male endurance cyclists | 3 g/day | 5 weeks | No significant effect on VO2peak or ventilatory threshold |
| Thongsawang, 2021 | C. sinensis powder | 12 male trained runners | 3 g/day | 2 weeks, crossover | Improved VO2max and VT2; no effect on VT1 |
| Savioli, 2022 | C. sinensis | 22 amateur marathoners (13 M, 9 F) | 2 g/day | 12 weeks | No significant change in VO2max or thresholds; 5 km time improved |
| Du and Song, 2019 | C. sinensis polysaccharide extract | 40 female wrestlers | 10 mg/kg/day | 3 weeks | No oxygen-uptake outcome reported |
| Nakamura, 2024 | C. militaris mycelium | 22 male university runners | 1,800 mg/day | 16 weeks | No oxygen-uptake outcome reported |
Three things jump out. The trials are small, the longest is 16 weeks, and the two that measured peak oxygen uptake over a meaningful period — five weeks in cyclists and twelve weeks in marathoners — both found nothing. The one clearly positive oxygen-uptake result came from a two-week crossover in twelve male runners.
The pooled numbers, and why they are thinner than they look
For Cordyceps sinensis the review reports a significant pooled result for peak oxygen uptake (P = 0.04, I² = 0%) and for ventilatory threshold (P = 0.03, I² = 0%), with endurance performance at P = 0.05 and I² = 20%. The review's own text calls that last one marginally significant while its abstract reports it as significant, which is the kind of internal disagreement worth noticing.
Each pooled outcome draws on only two or three studies. Confidence intervals appear in the forest plots rather than in the text, and the text does not name which studies went into which pooled outcome; the figure caption refers to three studies for endurance where the text describes two. An I² of zero across two trials is close to meaningless as a measure of consistency.
The authors are candid about the rest. Extraction methods, purity and active-compound concentrations varied enough to make the trials hard to compare. Thirteen of the fourteen included trials reported favourable outcomes, which the authors read as likely publication bias. Adverse events were poorly monitored and reported. Under RoB 2 assessment, only two trials were rated low risk of bias overall, one was rated high, and the remaining eleven raised some concerns. The high-risk rating went to Thongsawang 2021, the trial with the positive VO2max finding.
Species, preparation and dose: where the read-across breaks
The review's Cordyceps trials used either Cordyceps sinensis at 2 to 3 g a day of powder, a sinensis polysaccharide extract at 10 mg/kg a day, or Cordyceps militaris mycelium at 1,800 mg a day. The review's Table 1 names no product brands, so the particular preparation behind each trial cannot be read from it. The authors also attribute the split between the positive runner result and the null cyclist result partly to supplement origin, noting that the cyclist study used a commercially cultivated product, and partly to cordycepin content, which the trials did not report consistently. Their recommendation is that future work verify cordycepin content and cultivation origin.
That recommendation is the honest summary of the field. Two trials using the same genus at a similar gram-scale dose can be testing materially different substances, which is why the species and preparation distinction matters more than the headline, and why a dose figure on its own tells you less than it appears to. Animal work does not close the gap either: a 2020 study by Choi, Oh and Sung in Mycobiology gave five groups of ten male ICR mice an ethanol extract of cultured Cordyceps militaris fruiting bodies at 50 to 300 mg/kg for 12 weeks and measured grip strength and serum markers, running no endurance or time-to-exhaustion test at all. Mouse grip strength is not VO2 max, and mouse data is not human data.
What is in a Chaski tube
Chaski is a 600 g tube of 77% dark chocolate buttons, four buttons to the daily dose printed on the pack. The Cordyceps in it is Cordyceps sinensis mycelium; the Lion's Mane is a fruiting body extract. The cacao is single-origin Peruvian and Ecuadorian, low-temperature ground, bought from a Peruvian farm our founder has visited and whose farmers he has met. The sweetener is coconut sugar. There are no emulsifiers, no seed oils, no palm oil and no added cane sugar, and every batch is tested for lead, cadmium and pesticides. The Ginkgo biloba component is being replaced by 200 mg of Tremella fuciformis (10:1 fruiting body extract) per daily dose. We do not publish a Cordyceps quantity or a cordycepin figure for the tube, and the gram-scale daily doses, along with the powders, polysaccharide extracts and militaris mycelium used in the trials above, belong to those trials and not to this product. One tube is £44.99, or £32.99 a tube on the three-tube order, and there is a 30-day money-back guarantee on a full tube. The declaration is on the Chaski Cacao product page; the rest of this series is in the Chaski guides index.
Frequently Asked Questions
How many trials have tested Cordyceps on VO2 max?
Very few. The 2025 systematic review by Shu and colleagues in Frontiers in Nutrition identified 14 randomised controlled trials of fungal supplementation in athletes across 2004 to 2024, with 528 participants, and pooled only eight. Of the Cordyceps trials it tabulates, three reported an oxygen-uptake outcome: 22 male cyclists on 3 g a day for five weeks, 12 male runners on 3 g a day for two weeks, and 22 amateur marathoners on 2 g a day for twelve weeks. The pooled peak oxygen uptake estimate therefore rests on two or three studies.
Why do the Cordyceps VO2 max studies disagree?
The review offers two explanations and is careful to call them possibilities rather than findings. The first is the supplement itself: extraction method, purity, cultivation origin and cordycepin content varied between trials and were not reported consistently, so two studies of the same genus may not have tested the same substance. The second is the population, since cyclists and runners train differently and may respond differently. The review also rates the trial with the positive VO2max result as high risk of bias, driven by deviations from the intended intervention.
Was Cordyceps sinensis or militaris used in these trials?
Mostly sinensis. Four of the included Cordyceps trials used Cordyceps sinensis, at 2 to 3 grams a day of powder or a polysaccharide extract at 10 mg per kg of body weight a day. One used Cordyceps militaris mycelium at 1,800 mg a day for 16 weeks in 22 male university long-distance runners, and that trial reported haematological and muscle-damage outcomes rather than oxygen uptake. The review's table names no product brands, so which preparation or fermentation product sat behind each trial cannot be read from it.
Does Chaski state how much Cordyceps is in a daily dose?
No. We publish the species and the part used, Cordyceps sinensis mycelium, and we do not publish a milligram figure or a cordycepin figure for the tube because neither has been measured. The doses on this page are the doses used in the cited trials and belong to those trials. What is published for Chaski is composition and process: 77% dark, single-origin Peruvian and Ecuadorian cacao, low-temperature ground, coconut sugar, Lion's Mane as a fruiting body extract, no emulsifiers, no seed oils, no palm oil, no added cane sugar, and batch testing for lead, cadmium and pesticides.
Sources
See what is in the tube
Chaski Cacao — 600 g tube, 77% dark, Cordyceps sinensis mycelium, batch-tested